BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29031063)

  • 1. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
    Szychowski KA; Leja ML; Kaminskyy DV; Kryshchyshyn AP; Binduga UE; Pinyazhko OR; Lesyk RB; Tobiasz J; Gmiński J
    Eur J Med Chem; 2017 Dec; 141():162-168. PubMed ID: 29031063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New 4-thiazolidinone-based molecules Les-2769 and Les-3266 as possible PPARγ modulators.
    Bar M; Skóra B; Tabęcka-Łonczyńska A; Holota S; Khyluk D; Roman O; Lesyk R; Szychowski KA
    Bioorg Chem; 2022 Nov; 128():106075. PubMed ID: 35952447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Thiazolidinone-based derivatives do not affect differentiation of mouse embryo fibroblasts (3T3-L1 cell line) into adipocytes.
    Szychowski KA; Skóra B; Kryshchyshyn-Dylevych A; Kaminskyy D; Tobiasz J; Lesyk RB; Gmiński J
    Chem Biol Interact; 2021 Aug; 345():109538. PubMed ID: 34097888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-thiazolidinone-based derivatives rosiglitazone and pioglitazone affect the expression of antioxidant enzymes in different human cell lines.
    Szychowski KA; Skóra B; Kryshchyshyn-Dylevych A; Kaminskyy D; Khyluk D; Lesyk R
    Biomed Pharmacother; 2021 Jul; 139():111684. PubMed ID: 34243632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolidinedione-thiazolidinone hybrid molecules with potent cytotoxic effect in squamous cell carcinoma SCC-15 cells.
    Finiuk N; Kaleniuk E; Holota S; Stoika R; Lesyk R; Szychowski KA
    Bioorg Med Chem; 2023 Sep; 92():117442. PubMed ID: 37579525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of antineoplastic action of novel isomeric derivatives of 4-thiazolidinone.
    Chumak VV; Fil MR; Panchuk RR; Zimenkovsky BS; Havrylyuk DY; Lesyk RB; Stoika RS
    Ukr Biochem J; 2014; 86(6):96-105. PubMed ID: 25816610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of a cell-based peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of triterpenoids isolate from Alismatis Rhizoma].
    Li XY; Wang XH; Huang XQ; Wu TT; Xu W; Wu SS
    Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):4015-4022. PubMed ID: 28929690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel 4-thiazolidinone derivatives with promising anti-breast cancer activity: Synthesis, characterization, in vitro and in vivo results.
    Tahmasvand R; Bayat P; Vahdaniparast SM; Dehghani S; Kooshafar Z; Khaleghi S; Almasirad A; Salimi M
    Bioorg Chem; 2020 Nov; 104():104276. PubMed ID: 32992280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of novel anticancer 4-thiazolidinone derivatives.
    Szychowski KA; Leja ML; Kaminskyy DV; Binduga UE; Pinyazhko OR; Lesyk RB; Gmiński J
    Chem Biol Interact; 2017 Jan; 262():46-56. PubMed ID: 27965178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of 4-thiazolidinone derivatives containing indolin-2-one moiety with P-glycoprotein studied using K562 cell lines.
    Wang F; Liu Z; Wang J; Tao J; Gong P; Bao X; Zhao Y; Wang Y
    Eur J Med Chem; 2015 Aug; 101():126-32. PubMed ID: 26123642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives.
    Skóra B; Lewińska A; Kryshchyshyn-Dylevych A; Kaminskyy D; Lesyk R; Szychowski KA
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.
    Xiong X; Ye Y; Fu L; Dai B; Liu J; Jia J; Tang J; Li L; Wang L; Shen J; Mei C
    Invest New Drugs; 2009 Jun; 27(3):223-32. PubMed ID: 18704263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative and tumor inhibitory studies of 2,3 disubstituted 4-thiazolidinone derivatives.
    Sharath Kumar KS; Hanumappa A; Vetrivel M; Hegde M; Girish YR; Byregowda TR; Rao S; Raghavan SC; Rangappa KS
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3616-20. PubMed ID: 26152430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
    Wu J; Yu L; Yang F; Li J; Wang P; Zhou W; Qin L; Li Y; Luo J; Yi Z; Liu M; Chen Y
    Eur J Med Chem; 2014 Jun; 80():340-51. PubMed ID: 24794770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HL005--a new selective PPARγ antagonist specifically inhibits the proliferation of MCF-7.
    Lu W; Che P; Zhang Y; Li H; Zou S; Zhu J; Deng J; Shen X; Jiang H; Li J; Huang J
    J Steroid Biochem Mol Biol; 2011 Apr; 124(3-5):112-20. PubMed ID: 21296151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
    Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
    J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
    Bility MT; Thompson JT; McKee RH; David RM; Butala JH; Vanden Heuvel JP; Peters JM
    Toxicol Sci; 2004 Nov; 82(1):170-82. PubMed ID: 15310864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells.
    Onen-Bayram FE; Durmaz I; Scherman D; Herscovici J; Cetin-Atalay R
    Bioorg Med Chem; 2012 Sep; 20(17):5094-102. PubMed ID: 22867707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
    J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.